close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

30.36 2.78

Strong Buy

Prijsupdate 21 nov 2025, 20:34 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.77

Max

30.73

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+34.82% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

613M

2.8B

Vorige openingsprijs

27.58

Vorige sluitingsprijs

30.36

Nieuwssentiment

By Acuity

50%

50%

182 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 nov 2025, 23:07 UTC

Marktinformatie

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

DJ

Lezen

20 nov 2025, 22:22 UTC

Marktinformatie

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

DJ

Lezen

20 nov 2025, 22:08 UTC

Marktinformatie

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

DJ

Lezen

20 nov 2025, 21:57 UTC

Winsten

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

DJ

Lezen

20 nov 2025, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

20 nov 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

20 nov 2025, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

DJ

Lezen

20 nov 2025, 21:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

DJ

Lezen

20 nov 2025, 21:31 UTC

Winsten

Nvidia's Strong Results Show AI Fears Are Premature -- Update

DJ

Lezen

20 nov 2025, 21:23 UTC

Winsten
Acquisities, Fusies, Overnames

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

DJ

Lezen

20 nov 2025, 21:07 UTC

Winsten

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

DJ

Lezen

20 nov 2025, 21:06 UTC

Winsten

Webull 3Q Rev $156.9M >BULL

DJ

Lezen

20 nov 2025, 21:06 UTC

Winsten

Webull 3Q EPS 7c >BULL

DJ

Lezen

20 nov 2025, 21:05 UTC

Winsten

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

DJ

Lezen

20 nov 2025, 21:04 UTC

Winsten

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

DJ

Lezen

20 nov 2025, 21:04 UTC

Winsten

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

DJ

Lezen

20 nov 2025, 21:04 UTC

Winsten

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Backs FY26 Rev $21B-$21.19B >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit 1Q Consumer Rev $894M

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Backs FY26 Guidance

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

DJ

Lezen

20 nov 2025, 21:00 UTC

Winsten

Intuit 1Q Global Business Solutions Rev $3B

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

34.82% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 39.73 USD  34.82%

Hoogste 61 USD

Laagste 13.983 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Gebaseerd op 13 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

182 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,058.87

↑ +1.65%

JNJ

Johnson and Johnson

203.92

↑ +0.27%

ABBV

AbbVie Inc

236.16

↑ +2.85%

UNH

UnitedHealth Group Inc

319.35

↑ +2.41%

AZN

AstraZeneca PLC ADR

91.01

↑ +2.64%
help-icon Live chat